This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The fragile X-associated tremor/ataxia syndrome (FXTAS) is an X-linked genetic disorder in which the premutation (55–200 CGG repeats) in fragile X mental retardation 1 (FMR1) causes elevated levels of FMR1 mRNA, which in turn causes RNA toxicity through sequestration of critical proteins, dysregulated DNA repair processes, and production of FMRpolyG, a toxic protein produced from repeat-associated non-AUG (RAN) translation.1,2 FXTAS is associated with tremor and ataxia, and it presents in aging carriers of the premutation. However, there is evidence that the premutation causes changes in the brain far earlier than the onset of tremor and ataxia.3,4 The premutation is unmethylated, whereas those with fragile X syndrome have a full mutation (>200 CGG repeats), and the full mutation is methylated, leading to a lack of mRNA and a lack of fragile X mental retardation protein (FMRP).
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 2080
- © 2017 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
